These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9534750)
1. Type 1 cytokine response and treatment outcome of genital HPV lesions. Stellato G; Nieminen P; Aho M; Lehtinen T; Lehtinen M; Paavonen J Genitourin Med; 1997 Oct; 73(5):387-90. PubMed ID: 9534750 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic phase antibody response to the human papillomavirus type 16 E2 protein is associated with successful treatment of genital HPV lesions with systemic interferon alpha-2b. Stellato G; Paavonen J; Nieminen P; Hibma M; Vilja P; Lehtinen M Clin Diagn Virol; 1997 Feb; 7(3):167-72. PubMed ID: 9126686 [TBL] [Abstract][Full Text] [Related]
3. Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial. Yliskoski M; Syrjänen K; Syrjänen S; Saarikoski S; Nethersell A Gynecol Oncol; 1991 Oct; 43(1):55-60. PubMed ID: 1660011 [TBL] [Abstract][Full Text] [Related]
4. [Combination of beta-interferon and laser-CO2 therapy in female HPV genitalis]. Facchini C; Eremita GA; Bernabei A Minerva Ginecol; 1996 Sep; 48(9):345-9. PubMed ID: 8999380 [TBL] [Abstract][Full Text] [Related]
5. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha. Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745 [TBL] [Abstract][Full Text] [Related]
6. Treatment of genital HPV infection with carbon dioxide laser and systemic interferon alpha-2b. Nieminen P; Aho M; Lehtinen M; Vesterinen E; Vaheri A; Paavonen J Sex Transm Dis; 1994; 21(2):65-9. PubMed ID: 9071414 [TBL] [Abstract][Full Text] [Related]
7. Cytokines and disability in interferon-β-1b treated and untreated women with multiple sclerosis. Trenova AG; Slavov GS; Manova MG; Kostadinova II Arch Med Res; 2014 Aug; 45(6):495-500. PubMed ID: 25130430 [TBL] [Abstract][Full Text] [Related]
9. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix. Song SH; Lee JK; Seok OS; Saw HS Gynecol Oncol; 2007 Mar; 104(3):732-8. PubMed ID: 17188341 [TBL] [Abstract][Full Text] [Related]
10. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment]. Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835 [TBL] [Abstract][Full Text] [Related]
11. Treatment with interferon for genital HPV in HIV-positive and HIV-negative women. Semprini AE; Stillo A; Marcozzi S; Castagna C; Fiore S; Radaelli U Eur J Obstet Gynecol Reprod Biol; 1994 Feb; 53(2):135-7. PubMed ID: 7910799 [TBL] [Abstract][Full Text] [Related]
12. [Beta-interferon treatment of HPV infections of the lower genital tract in women]. Bernasconi F; Gritti P; Ersettigh G; Galli F; Arienti S Minerva Ginecol; 1994 Nov; 46(11):609-18. PubMed ID: 7854565 [TBL] [Abstract][Full Text] [Related]
13. Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated lesions. Scala M; Bonelli G; Gipponi M; Margarino G; Muzza A Anticancer Res; 2002; 22(2B):1171-6. PubMed ID: 12168920 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of imiquimod indirect antiviral activity]. Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973 [TBL] [Abstract][Full Text] [Related]
15. [The effect of viral infections on the cytokine profile in pregnant women with obstetric complications and immunotherapy with human alpha2b interferon]. Klimova RR; Malinovskaia VV; Parshina OV; Guseva TS; Novikova SV; Torshina ZV; Zarochentseva NV; Tsibizov AA; Kushch AA Vopr Virusol; 2013; 58(1):18-23. PubMed ID: 23785756 [TBL] [Abstract][Full Text] [Related]
16. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K; Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a. Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum cytokines IL-1beta, sIL-2R, IL-6, TNF-alpha, and IFN-v in acute coronary syndrome. Wang YN; Che SM; Ma AQ Chin Med Sci J; 2004 Jun; 19(2):120-4. PubMed ID: 15250248 [TBL] [Abstract][Full Text] [Related]